<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview of cancer prevention
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview of cancer prevention
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview of cancer prevention
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Graham A Colditz, MD, DrPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Seres, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul J Hesketh, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jane Givens, MD, MSCE
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 06, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both screening and prevention can reduce mortality from many cancers. Screening detects abnormalities before they are clinically apparent, allowing for intervention either before cancer develops or at an early stage, when treatment is most often effective. Prevention strategies focus on modifying environmental and lifestyle risk factors that promote cancer. Despite a robust knowledge of what factors decrease cancer risk, implementation of cancer prevention lags [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         This topic reviews the major modifiable cancer risk factors and briefly addresses cancer chemoprevention. More detailed discussion of prevention strategies for specific cancers can be found elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6949.html" rel="external">
          "Chemoprevention strategies in prostate cancer"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/756.html" rel="external">
          "Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2606.html" rel="external">
          "Epidemiology and risk factors for colorectal cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The roles of physical activity, dietary patterns, and weight in cancer survivors are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14222.html" rel="external">
          "The roles of diet, physical activity, and body weight in cancer survivors"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2983269019">
         <span class="h1">
          GENERAL LIFESTYLE RECOMMENDATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lifestyle factors have been linked to a variety of malignancies, including those common across the globe, such as lung, colorectal, prostate, and breast cancer [
         <a href="#rid3">
          3-6
         </a>
         ]. While multiple cancer risk factors have been identified, tobacco use, excess weight, poor diet, and physical inactivity have been implicated in the majority of cancer deaths in the United States and worldwide [
         <a href="#rid7">
          7,8
         </a>
         ]. The Global Burden of Disease study estimated that in 2019, 50.6 percent of worldwide cancer deaths in males, and 36.3 percent of those in females were attributable to behavioral, environmental and occupational, or metabolic risk factors [
         <a href="#rid9">
          9
         </a>
         ]. Smoking was the leading risk factor for all adults, while other important risk factors included alcohol use, high body mass index, and unsafe sex.
        </p>
        <p>
         Our general lifestyle recommendations include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Avoid tobacco
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Be physically active
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maintain a healthy weight
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eat a diet rich in fruits, vegetables, and whole grains and low in saturated/trans fat, red meat, and processed meat
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Limit alcohol (zero is best)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protect against sexually transmitted infections; this includes vaccination against human papillomavirus (HPV)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protect against the sun and avoid tanning beds
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Get regular screening for breast, cervical, colorectal, and lung cancer (if applicable based on smoking history)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3502141187">
         <span class="h1">
          INFECTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is estimated that 13 percent of all new cancers worldwide are due to infections [
         <a href="#rid10">
          10
         </a>
         ]. Viruses may increase cancer risk through cellular transformation, disruption of cell cycle control, increased cell turnover rates, and immune suppression [
         <a href="#rid11">
          11
         </a>
         ]. Multiple links between infectious agents and cancer have been established:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Human papillomavirus (HPV) with cervical and other anogenital cancers as well as squamous cell cancers of the head and neck [
         <a href="#rid12">
          12
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/8031.html" rel="external">
          "Virology of human papillomavirus infections and the link to cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3378.html" rel="external">
          "Epidemiology, staging, and clinical presentation of human papillomavirus associated head and neck cancer"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatitis B virus (HBV) and hepatitis C virus (HCV) with hepatocellular carcinoma [
         <a href="#rid13">
          13
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/3599.html" rel="external">
          "Epidemiology and risk factors for hepatocellular carcinoma"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Human T-cell lymphotropic virus type 1 (HTLV-1) with adult T-cell leukemia [
         <a href="#rid14">
          14
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4536.html" rel="external">
          "Treatment of large granular lymphocyte leukemia"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HIV with Kaposi sarcoma as well as with non-Hodgkin lymphoma [
         <a href="#rid15">
          15
         </a>
         ] and with multiple non-acquired immunodeficiency syndrome (AIDS)-defining malignancies [
         <a href="#rid16">
          16
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/8035.html" rel="external">
          "HIV infection and malignancy: Epidemiology and pathogenesis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Human herpes virus 8 (HHV-8) with Kaposi sarcoma and primary effusion lymphoma [
         <a href="#rid17">
          17,18
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/8319.html" rel="external">
          "Human herpesvirus-8 infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epstein-Barr virus (EBV) with Burkitt lymphoma [
         <a href="#rid17">
          17
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4723.html" rel="external">
          "Pathobiology of Burkitt lymphoma"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The bacterium
         <em>
          Helicobacter pylori
         </em>
         with gastrointestinal malignancies including gastric cancer [
         <a href="#rid19">
          19
         </a>
         ] and mucosa-associated lymphoid tissue (MALT) lymphomas (see
         <a class="medical medical_review" href="/z/d/html/2514.html" rel="external">
          "Association between Helicobacter pylori infection and gastrointestinal malignancy"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Liver flukes with cholangiocarcinoma and hepatocellular carcinoma [
         <a href="#rid20">
          20
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/5674.html" rel="external">
          "Liver flukes: Clonorchis, Opisthorchis, and Metorchis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H926853648">
         <span class="h2">
          Interventions to decrease risk from infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of infections associated with cancer are due to viruses that are spread through contact with infected blood or body fluids. Strategies to prevent such transmission include safer sexual practices, use of sterile disposable needles for a single patient in health care settings, needle exchange programs, regulation of tattooing, continued screening of blood, organ, and semen donors, and the development of artificial blood products. (See
         <a class="medical medical_review" href="/z/d/html/7595.html" rel="external">
          "Prevention of sexually transmitted infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/113.html" rel="external">
          "Sexual development and sexuality in children and adolescents", section on 'Develop risk-reduction strategies'
         </a>
         .)
        </p>
        <p>
         For some viruses, specific interventions are available to either prevent infection or delay progression to cancer after infection:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HPV vaccination is recommended for all children, as well as for young women and young men who were not vaccinated during childhood. Additionally, cervical cancer screening has dramatically reduced the incidence of cervical cancer where screening is widely available [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8325.html" rel="external">
          "Human papillomavirus vaccination"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7575.html" rel="external">
          "Screening for cervical cancer in resource-rich settings"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HBV vaccination for adults at high risk of HBV infection to reduce viral infection and subsequent hepatocellular carcinoma. (See
         <a class="medical medical_review" href="/z/d/html/3641.html" rel="external">
          "Hepatitis B virus immunization in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HCV screening is recommended in all adults ages 18 to 79 years. This is a one-time screening for most adults and periodic screening for those at high risk, such as patients with a history of injection drug use [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pre-exposure prophylaxis (PrEP) can significantly lower the risk of HIV infection in high-risk groups, and retroviral therapy for HIV infection has greatly altered the course of disease and associated cancers. Antiretroviral therapy (ART) has been shown to reduce the incidence of AIDS-related lymphoma [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3773.html" rel="external">
          "Selecting antiretroviral regimens for treatment-naïve persons with HIV-1: General approach"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreasing the hepatitis B viral load by treatment with interferon or nucleoside/tide analogues in patients with chronic hepatitis B infection was associated with a decreased risk for hepatoma [
         <a href="#rid24">
          24,25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3642.html" rel="external">
          "Hepatitis B virus: Overview of management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Excess alcohol use may play a role in cancer development in patients with chronic HBV and HCV infections and should be avoided. Preliminary data suggest that antiviral therapy may reduce the risk of cancer in patients with chronic HCV infections, with reduction of HCV RNA, but the long-term effect of antiviral therapy on cancer risk is not known [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          TOBACCO USE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tobacco use is the most important preventable causes of cancer and accounts for 21 percent of total cancer deaths worldwide [
         <a href="#rid27">
          27
         </a>
         ] and 30 percent of all cancer-related deaths in the United States [
         <a href="#rid28">
          28
         </a>
         ]. Approximately one-half of all smokers die of a tobacco-related disease, and adult smokers lose an average of 13 years of life due to tobacco use [
         <a href="#rid28">
          28,29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4640.html" rel="external">
          "Cigarette smoking and other possible risk factors for lung cancer"
         </a>
         .)
        </p>
        <p>
         Smoking is the strongest risk factor for lung cancer, increasing risk 10- to 20-fold [
         <a href="#rid30">
          30,31
         </a>
         ]. Smoking is also implicated as a causative factor for leukemia as well as cancers of the oral cavity, nasal cavity, paranasal sinuses, nasopharynx, larynx, esophagus, pancreas, liver, stomach, cervix, kidney, large bowel, and bladder [
         <a href="#rid32">
          32,33
         </a>
         ]. Studies also suggest that smoking is associated with increased incidence of breast cancer as well as prostate cancer, particularly in African American individuals [
         <a href="#rid34">
          34-38
         </a>
         ].
        </p>
        <p>
         Tobacco acts on multiple stages of carcinogenesis; it delivers carcinogens directly to tissues, causes irritation and inflammation, and interferes with the body's natural protective barriers [
         <a href="#rid39">
          39
         </a>
         ]. The dangers of tobacco are most commonly associated with cigarette smoking but also occur with cigars, pipes, smokeless tobacco, and exposure to environmental (secondhand) tobacco smoke. (See
         <a class="medical medical_review" href="/z/d/html/6919.html" rel="external">
          "Secondhand smoke exposure: Effects in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3791910912">
         <span class="h2">
          Tobacco cessation and prevention
         </span>
         <span class="headingEndMark">
          —
         </span>
         Significant health benefits accompany quitting, even for longtime tobacco users. The health benefits of quitting can be seen at all ages and can be measured almost immediately after cessation [
         <a href="#rid40">
          40
         </a>
         ]. Smoking cessation leads to reduced risk of most tobacco-related diseases and a decrease in all-cause mortality.
        </p>
        <p class="bulletIndent1">
         Tobacco cessation is associated with a reduction in cancer risk, and among smokers with a smoking-related cancer, smoking cessation decreases the risk of developing a second smoking-related malignancy and may improve the outcomes of cancer treatment [
         <a href="#rid38">
          38,41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16706.html" rel="external">
          "Benefits and consequences of smoking cessation", section on 'Benefits of smoking cessation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The role of the health care provider in smoking cessation includes advice and counseling, referrals to behavioral therapy and support groups, and prescriptions for
         <a class="drug drug_general" data-topicid="9698" href="/z/d/drug information/9698.html" rel="external">
          nicotine
         </a>
         replacement and other medications [
         <a href="#rid42">
          42,43
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16635.html" rel="external">
          "Pharmacotherapy for smoking cessation in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6920.html" rel="external">
          "Behavioral approaches to smoking cessation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">
          "Overview of smoking cessation management in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Programs and policies that reduce youth initiation and facilitate smoking cessation should be implemented in both clinical and community settings to prevent initiation of tobacco use [
         <a href="#rid44">
          44
         </a>
         ]. Many of these same efforts should also be extended to the prevention of youth initiation and use of e-cigarettes, which, along with other possible harms, may increase the risk of combustible tobacco use. (See
         <a class="medical medical_review" href="/z/d/html/14583.html" rel="external">
          "Prevention of smoking and vaping initiation in children and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H349227082">
         <span class="h1">
          PHYSICAL ACTIVITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Decreased physical activity is associated with an increased risk for cancer [
         <a href="#rid45">
          45-47
         </a>
         ], and it is estimated that a sedentary lifestyle is associated with 5 percent of cancer deaths [
         <a href="#rid48">
          48
         </a>
         ]. However, the optimal duration, intensity, and frequency of physical activity that may afford cancer protection is unknown. Physical activity during certain periods of life, such as adolescence, may offer additional protection against disease, particularly for breast cancer [
         <a href="#rid49">
          49,50
         </a>
         ].
        </p>
        <p>
         Greater physical activity is associated with a decreased risk for many different types of cancers, [
         <a href="#rid47">
          47,51-53
         </a>
         ], but the most compelling data are in the association with reduction in colon and breast cancer risk [
         <a href="#rid47">
          47,51,54-59
         </a>
         ]. For example, In a meta-analysis of 52 studies, there was a 24 percent reduced risk of colon cancer when comparing the most versus the least active individuals (relative risk [RR] 0.76, 95% CI 0.72-0.81) [
         <a href="#rid51">
          51
         </a>
         ]. In a subsequent meta-analysis including 21 studies, there were similar findings of decreased risk for both proximal and distal colon cancers [
         <a href="#rid60">
          60
         </a>
         ]. In another meta-analysis, increased physical activity was associated with a 16 percent reduction in the risk of developing adenomatous colon polyps (RR 0.84, 95% CI 0.77-0.92) [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
         Several mechanisms have been proposed to explain the possible protective effect of physical activity, including reduction in circulating levels of insulin, hormones, and other growth factors; impact on prostaglandin levels; improved immune function, and altered bile acid metabolism [
         <a href="#rid62">
          62-64
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H737985004">
         <span class="h2">
          Strategies to encourage physical activity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Strategies for clinicians to encourage physical exercise in their patients are presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/120020.html" rel="external">
          "Exercise prescription and guidance for adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16524.html" rel="external">
          "Physical activity and exercise in older adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H349227125">
         <span class="h1">
          OBESITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Excess weight is associated with an increased risk of 13 types of cancer [
         <a href="#rid65">
          65
         </a>
         ]. The relationship between obesity and cancer risk is discussed in detail separately, and associations between obesity and specific cancer types are discussed in the individual topics that cover the specific cancer type. (See
         <a class="medical medical_review" href="/z/d/html/5370.html" rel="external">
          "Overweight and obesity in adults: Health consequences", section on 'Cancer'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1221024049">
         <span class="h2">
          Weight loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Weight loss methods including bariatric surgery have been associated with decreased cancer mortality. In one retrospective cohort study, bariatric surgery was associated with a 60 percent reduction in cancer mortality (5.5 versus 13.3 per 10,000 person-years) over seven-year follow-up [
         <a href="#rid66">
          66
         </a>
         ]. In another retrospective cohort study, bariatric surgery was associated with a 33 percent reduction in overall cancer risk, with greater reductions of 40 to 55 percent in specific weight-related cancers: colon cancer, postmenopausal breast cancer, endometrial cancer, and pancreatic cancer [
         <a href="#rid67">
          67
         </a>
         ]. The International Agency for Research on Cancer (IARC) analysis also found that bariatric surgery was associated with a reduced risk of endometrial and breast cancers [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
         Intentional, nonsurgical weight loss has also been associated with reduced cancer risk, though there are fewer studies, and these are complicated by difficulty controlling for intentional versus unintentional weight loss. In the Nurses’ Health Study, sustained weight loss of 22 pounds or more in women who had not used menopausal hormone therapy lowered breast cancer risk [
         <a href="#rid68">
          68
         </a>
         ]. In two Women’s Health Initiative studies, compared with women who maintained stable weight during a mean follow-up of 11.4 years, women who had lost weight had a 29 percent lower risk of endometrial cancer (hazard ratio [HR] 0.71, 95% CI 0.54-0.95) and a 12 percent lower risk of postmenopausal breast cancer (HR 0.88, 95% CI 0.78‐0.98) [
         <a href="#rid69">
          69,70
         </a>
         ].
        </p>
        <p>
         Weight loss strategies are presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5371.html" rel="external">
          "Obesity in adults: Overview of management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4281114691">
         <span class="h1">
          ALCOHOL
         </span>
         <span class="headingEndMark">
          —
         </span>
         Alcohol consumption increases the risk of multiple cancers, which is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2781.html" rel="external">
          "Overview of the risks and benefits of alcohol consumption", section on 'Cancer'
         </a>
         .)
        </p>
        <p>
         Several mechanisms have been postulated to account for the carcinogenicity of alcohol [
         <a href="#rid71">
          71
         </a>
         ]. Its solvent properties may allow carcinogens to penetrate cell membranes. Alcohol increases estrogen levels and impacts folate metabolism. Alcohol may also act as an irritant, causing increased cell production; as a transporter carrying carcinogens; as an inhibitor of DNA methylation; or as a prometabolite for identified carcinogens such as acetaldehyde [
         <a href="#rid71">
          71-73
         </a>
         ].
        </p>
        <p>
         Treatment of alcohol use disorder is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/108891.html" rel="external">
          "Alcohol use disorder: Treatment overview"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3018263739">
         <span class="h1">
          ENVIRONMENTAL EXPOSURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Potentially modifiable or avoidable environmental contributors to increased cancer incidence include exposure to excessive solar radiation or to artificial ultraviolet radiation; air pollution; radon gas in enclosed environments; and arsenic in drinking water.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sun and ultraviolet radiation exposure
         </strong>
         – Radiation from the sun is the primary cause of both melanomatous and nonmelanomatous skin cancer [
         <a href="#rid74">
          74
         </a>
         ]. Ultraviolet radiation causes genetic mutations and interferes with the cutaneous immune system, limiting the body's ability to reject abnormal cells. Risk of squamous cell and basal cell cancer appear to correlate with total lifetime sun exposure [
         <a href="#rid74">
          74
         </a>
         ]. Cumulative sun exposure may also increase melanoma risk, but repeated intense exposures leading to blistering burns, particularly in childhood and adolescence, may be even more dangerous [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Ultraviolet exposure from tanning beds has been classified as a human carcinogen, with a 75 percent increase in risk for melanoma in patients who utilized tanning booths before age 35 [
         <a href="#rid76">
          76
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4844.html" rel="external">
          "Melanoma: Epidemiology and risk factors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Air pollution
         </strong>
         – Diesel exhaust and particulate matter air pollution have been associated with increased risk of lung cancer. These are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4640.html" rel="external">
          "Cigarette smoking and other possible risk factors for lung cancer", section on 'Air pollution and diesel exhaust'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Radon
         </strong>
         – The small increase in lung cancer risk associated with increased indoor radon levels is described separately. (See
         <a class="medical medical_review" href="/z/d/html/4640.html" rel="external">
          "Cigarette smoking and other possible risk factors for lung cancer", section on 'Radon'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arsenic
         </strong>
         – Long-term exposure to elevated arsenic levels in drinking water is associated with an increase in the risk of certain cancers, with strong evidence supporting a dose-response relationship for bladder cancer [
         <a href="#rid77">
          77,78
         </a>
         ]. Most municipal water supplies are tested regularly for arsenic to ensure safe levels. Private drinking wells are more likely to have elevated levels and should be professionally tested regularly. (See
         <a class="medical medical_review" href="/z/d/html/2778.html" rel="external">
          "Arsenic exposure and chronic poisoning", section on 'Drinking water'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H777919985">
         <span class="h2">
          Recommendations for sun/ultraviolet protection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Individuals should generally limit the time spent in the sun, especially between the hours of 10 AM and 4 PM; wear hats, sunglasses, and other protective clothing; and use sunscreen with sun protection factor (SPF) 30 or higher. Because the majority of lifetime sun exposure usually occurs during childhood and adolescence, protective behaviors early in life will provide the greatest benefit. The Environmental Protection Agency (EPA) offers simple
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.epa.gov%2Fsunsafety%2Faction-steps-sun-protection&amp;token=%2B0rEyHQ1T7gRoXXx698zAur3E2PGtiYptxe%2Bs2JQxSEfqn9OLi5R38Vby00IMo9b4mQmBNdiFJ%2FwSDjzsiOTtQ%3D%3D&amp;TOPIC_ID=6893" target="_blank">
          action steps for sun protection
         </a>
         . In addition, the World Health Organization (WHO) has
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fpublications%2Fi%2Fitem%2F9789241512596&amp;token=mr3MkQMxxRm373pPGLTYB%2B8L7rJeOJtqYOfpSLq18h7bLDDnWC3XicBcpsIGU3t1epClj84AHQoQzdBOmdtD3w%3D%3D&amp;TOPIC_ID=6893" target="_blank">
          recommended
         </a>
         that tanning bed use should be avoided entirely [
         <a href="#rid79">
          79
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4842.html" rel="external">
          "Primary prevention of melanoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6624.html" rel="external">
          "Sunburn"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          DIET
         </span>
         <span class="headingEndMark">
          —
         </span>
         Specific components of diet as well as overall dietary patterns have been studied in relation to the risk of cancer. Overall, dietary fat, fruits, and vegetables have not consistently been shown to affect cancer risk [
         <a href="#rid80">
          80,81
         </a>
         ]. However, certain dietary patterns, as well as intake of other nutrients, particularly certain micronutrients, may offer a degree of protection against certain malignancies.
        </p>
        <p>
         Specific dietary patterns may affect the incidence and mortality rate of certain types of cancer. These are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2606.html" rel="external">
          "Epidemiology and risk factors for colorectal cancer", section on 'Diet'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4640.html" rel="external">
          "Cigarette smoking and other possible risk factors for lung cancer", section on 'Dietary factors'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6938.html" rel="external">
          "Risk factors for prostate cancer", section on 'Diet'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women", section on 'Low-fat dietary pattern in postmenopausal women'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2606.html" rel="external">
          "Epidemiology and risk factors for colorectal cancer", section on 'Red and processed meat'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2606.html" rel="external">
          "Epidemiology and risk factors for colorectal cancer", section on 'Diet'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4640.html" rel="external">
          "Cigarette smoking and other possible risk factors for lung cancer", section on 'Dietary factors'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6938.html" rel="external">
          "Risk factors for prostate cancer", section on 'Diet'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women", section on 'Low-fat dietary pattern in postmenopausal women'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2606.html" rel="external">
          "Epidemiology and risk factors for colorectal cancer", section on 'Diet'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4640.html" rel="external">
          "Cigarette smoking and other possible risk factors for lung cancer", section on 'Dietary factors'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6938.html" rel="external">
          "Risk factors for prostate cancer", section on 'Diet'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women", section on 'Low-fat dietary pattern in postmenopausal women'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2606.html" rel="external">
          "Epidemiology and risk factors for colorectal cancer", section on 'Diet'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4640.html" rel="external">
          "Cigarette smoking and other possible risk factors for lung cancer", section on 'Dietary factors'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6938.html" rel="external">
          "Risk factors for prostate cancer", section on 'Diet'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women", section on 'Low-fat dietary pattern in postmenopausal women'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1042024163">
         <span class="h2">
          Advice on dietary patterns
         </span>
         <span class="headingEndMark">
          —
         </span>
         We agree with the 2020 American Cancer Society guideline on diet and physical activity for cancer prevention which recommends a healthy diet, defined as having a variety of vegetables (dark green, red and orange, fiber-rich legumes and others), fruits, and whole grains, and limiting or not including red and processed meats, sugar-sweetened beverages, or highly processed foods and refined grain products [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
         A meta-analysis of prospective studies of “healthy” and “unhealthy” dietary patterns found favorable associations between a healthy diet and lower risks of certain types of cancers [
         <a href="#rid83">
          83
         </a>
         ]. In a large cohort study of the Mediterranean diet (ie, high intake of fruits, vegetables, nuts, legumes, whole wheat bread, fish, and olive oil), a two-point increase in dietary compliance (on a 10-point scale) was associated with a 4 to 12 percent lower risk of cancer [
         <a href="#rid84">
          84,85
         </a>
         ]. In a study of cancer risk and mortality [
         <a href="#rid86">
          86
         </a>
         ], all-cause mortality was 17 percent lower with a vegetarian diet than for non-vegetarians.
        </p>
        <p>
         By contrast, studies of a "Western" diet have found an association with increased risk of some cancers compared with adherence to a "prudent" diet, although the components of a "Western" diet vary from study to study [
         <a href="#rid87">
          87
         </a>
         ]. In another cohort study, diets high in ultra-processed foods were associated with greater than 10 percent increases in the risk of all-cancer and breast cancer [
         <a href="#rid88">
          88
         </a>
         ]. Ultra-processed foods included mass-produced packaged breads, packaged snacks, sodas, reconstituted meat products with nitrite preservatives, instant soups, frozen meals, and others.
        </p>
        <p>
         Further information on a healthy diet is presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5364.html" rel="external">
          "Healthy diet in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3694779650">
         <span class="h2">
          Diet components
         </span>
         <span class="headingEndMark">
          —
         </span>
         While associations have been found between dietary patterns and cancer incidence, none of the following studies should be construed as supportive of dietary supplement use for cancer prevention. Certain of the following components may have toxicity (flavonoids may cause hepatic failure), and supplementation with certain compounds (eg,
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         ) has been associated with increased cancer incidence.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Dietary fat
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dietary fat has been extensively studied as a possible factor explaining the variation in international cancer rates; however, data to support this theory are limited. This is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4555.html" rel="external">
          "Dietary fat", section on 'Cancer'
         </a>
         .)
        </p>
        <p>
         Intake of large amounts of alpha-linoleic acid and low amounts of linoleic acid may increase prostate cancer risk, which is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6938.html" rel="external">
          "Risk factors for prostate cancer", section on 'Animal fat'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Red meat
         </span>
         <span class="headingEndMark">
          —
         </span>
         Consumption of red and processed meat is associated with an increased risk of colorectal cancer and advanced prostate cancer [
         <a href="#rid89">
          89-91
         </a>
         ]. The International Agency for Research on Cancer (IARC) classifies processed meat as a Group 1 human carcinogen [
         <a href="#rid92">
          92
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2606.html" rel="external">
          "Epidemiology and risk factors for colorectal cancer", section on 'Other risk factors'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Fruits and vegetables
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evidence that greater intake of fruits and vegetables decreases cancer risk is inconsistent [
         <a href="#rid93">
          93-96
         </a>
         ]. Data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study, a cohort study of nearly 500,000 European adults followed for nine years, found only a weak association between increased intake of fruits and vegetables and overall risk of cancer (hazard ratio [HR] 0.97, 95% CI 0.96-0.99) [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p>
         Some study findings for specific cancers include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Many epidemiologic studies [
         <a href="#rid97">
          97,98
         </a>
         ], though not all [
         <a href="#rid99">
          99
         </a>
         ], suggest a weak association between the intake of a diet high in fruits and vegetables and protection from colorectal cancer. A pooled analysis of 14 cohort studies (n &gt;750,000), including the previous study [
         <a href="#rid99">
          99
         </a>
         ], concluded that eating more than 800 g/day of fruit and vegetables, compared with less than 200 g/day, decreased risk for distal colon cancer (relative risk [RR] 0.74) but not for proximal cancer [
         <a href="#rid100">
          100
         </a>
         ]. A subsequent meta-analysis of 19 cohort studies concluded a weaker protective effect, with most of the risk reduction attributable identified at a far lower threshold (100 g/day) of fruit and vegetable intake [
         <a href="#rid101">
          101
         </a>
         ]. A meta-analysis of the relationship between fiber and colorectal cancer found no significant association between fruit, vegetable, or legume fiber and the incidence of colorectal cancer [
         <a href="#rid102">
          102
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence is somewhat stronger, albeit still weak, for a possible protective link between prostate cancer and consumption of tomato products. Initial studies provided conflicting results, and a systematic review performed by the US Food and Drug Administration (FDA) found "very limited evidence" to support an association between tomato consumption and reduced risk of prostate or other (ovarian, gastric, and pancreatic) cancers [
         <a href="#rid103">
          103
         </a>
         ]. An analysis of a prospective cohort of 51,529 men from the Health Professionals Follow-up Study has suggested that dietary intake of lycopene is associated with a lower incidence of prostate cancer and a decreased risk of lethal prostate cancer [
         <a href="#rid104">
          104
         </a>
         ]. Analysis of tumor biomarkers was consistent with a possible role of inhibition of tumor neoangiogenesis as the mechanism underlying these observations. (See
         <a class="medical medical_review" href="/z/d/html/6938.html" rel="external">
          "Risk factors for prostate cancer", section on 'Lycopene and tomato based products'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In an analysis of the Pooling Project of Prospective Studies of Diet and Cancer, total fruit and vegetable intake was inversely related to the incidence of estrogen-receptor (ER)-negative breast cancer, with vegetable intake alone associated with an 18 percent risk reduction comparing the highest quintile of intake with the lowest [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis found that intake of high amounts of soy (20 mg/day of isoflavone) in Asian women was associated with a decreased risk for breast cancer compared with Asian women consuming lower amounts (5 mg/day) [
         <a href="#rid106">
          106
         </a>
         ]. However, even the lowest intake of soy isoflavones in the Asian population was more than fivefold the "high" intake (0.8 mg/day) of women in Western countries, where studies have not shown a protective effect for soy. In another meta-analysis, Chinese women who were in the highest quintile of soy intake had a decreased risk of lung cancer compared with those in the lowest quintile [
         <a href="#rid107">
          107
         </a>
         ]. Diets with increased intake of foods high in flavonoids, such as tomatoes, green peppers, berries, and citrus fruits have been associated with a modest decrease in breast cancer risk in Western populations [
         <a href="#rid108">
          108
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Dairy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several studies suggest that intake of low-fat dairy products may protect against breast cancer, mainly in premenopausal women [
         <a href="#rid109">
          109-112
         </a>
         ]. In the largest prospective cohort study of over 88,000 women in the Nurses' Health Study, there was an inverse association between breast cancer risk and the intake of low-fat dairy products, calcium (mainly dairy intake), and vitamin D (mainly non-dairy intake) in premenopausal but not postmenopausal women [
         <a href="#rid109">
          109
         </a>
         ]. By contrast, a large pooled analysis of eight prospective studies mainly comprising postmenopausal women did not find a strong association between dairy intake and breast cancer risk [
         <a href="#rid113">
          113
         </a>
         ].
        </p>
        <p>
         The relationship between dairy intake and ovarian cancer is uncertain, with most studies finding no association [
         <a href="#rid114">
          114-117
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Fiber
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dietary fiber intake is associated with a reduction in colorectal cancer [
         <a href="#rid118">
          118
         </a>
         ]. Though there has been some variance in results of individual observational studies, a World Cancer Research Fund Continuous Update Project dose response meta-analysis has found a decrease in risk of colorectal cancer with increasing intake of fiber. This analysis, including 15 studies with a total of 14,876 cases, showed a 9 percent lower risk of disease for every 10 g/day intake of foods containing fiber (RR 0.91, 95% CI 0.88-0.94). Similar inverse associations were found in North American (RR 0.92, 95% CI 0.88-0.96) and European (RR 0.90, 95% CI 0.85-0.96) populations [
         <a href="#rid119">
          119
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2606.html" rel="external">
          "Epidemiology and risk factors for colorectal cancer", section on 'Fiber'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Glycemic load
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insulin and insulin-like growth factors promote cell proliferation, and it is hypothesized that hyperinsulinemia may promote certain cancers [
         <a href="#rid120">
          120
         </a>
         ]. An increased risk for certain cancers has been associated with diabetes (primarily type 2) [
         <a href="#rid121">
          121
         </a>
         ]. Patients with diabetes have a twofold or greater risk of cancers of the liver, pancreas, and endometrium and a slightly lower but increased risk for cancers of the colon, breast and bladder; the risk of prostate cancer is decreased in patients with diabetes [
         <a href="#rid122">
          122
         </a>
         ]. However, studies of glycemic load and risk of breast or colon cancer show mixed results [
         <a href="#rid123">
          123-136
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Omega-3 fatty acids and dietary fish
         </span>
         <span class="headingEndMark">
          —
         </span>
         A systematic review of prospective studies evaluating the effect of omega-3 fatty acid consumption on tumor incidence concluded that there is no association between omega-3 fatty acids and cancer risk for 11 different types of cancer [
         <a href="#rid137">
          137
         </a>
         ]. Ten studies evaluated in this review reported significant findings, but individual studies indicated both increased and decreased risk with no consistent pattern. A subsequent randomized trial found an increase in cancer risk for women treated with omega-3 fatty acids, but not for men [
         <a href="#rid138">
          138
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H970411118">
         <span class="h3">
          Coffee and caffeine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Coffee intake has been associated with a lower risk of certain cancers, including endometrial and liver cancer [
         <a href="#rid139">
          139,140
         </a>
         ]. World Cancer Research Fund Continuous Update Project dose response meta-analyses found a significant 7 percent lower risk of endometrial cancer (RR 0.93, 95% CI 0.91-0.96) and a 14 percent lower risk of liver cancer (RR 0.86, 95% CI 0.81-0.90) for every one cup of coffee/day. For endometrial cancer, the results were similar for decaffeinated coffee, a significant 8 percent lower risk (RR 0.92, 95% CI 0.87-0.97) per one cup/day. The effects of caffeine on several types of cancer are described separately. (See
         <a class="medical medical_review" href="/z/d/html/5369.html" rel="external">
          "Benefits and risks of caffeine and caffeinated beverages", section on 'Cancer'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          VITAMINS AND MICRONUTRIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple observational and prospective studies and systematic reviews of the use of supplemental vitamins and minerals to prevent cancer have had negative results [
         <a href="#rid141">
          141-145
         </a>
         ], although there are some positive studies [
         <a href="#rid146">
          146,147
         </a>
         ]. However, supplements may be appropriate for some groups whose diets may be deficient for a variety of reasons. Any decision to take supplements should take place after an individual discussion with a health care provider.
        </p>
        <p>
         The World Cancer Research Fund and American Institute for Cancer Research recommend against using supplements to prevent cancer [
         <a href="#rid148">
          148
         </a>
         ]. People are encouraged to consume a healthy diet to meet nutritional needs. Further information on vitamin supplementation to prevent cancer is provided elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">
          "Vitamin intake and disease prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3683684200">
         <span class="h2">
          Specific components
         </span>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h3">
          Vitamin D
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies of the relationship between vitamin D intake or serum levels of 25(OH)D and cancer risk have been inconsistent [
         <a href="#rid149">
          149
         </a>
         ]. Studies vary in regard to participants (sex, baseline serum levels), types of cancer evaluated, and dose of vitamin D. Overall, it does not appear that vitamin D supplements should be prescribed to decrease cancer risk [
         <a href="#rid150">
          150
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13915.html" rel="external">
          "Vitamin D and extraskeletal health", section on 'Cancer'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Calcium
         </span>
         <span class="headingEndMark">
          —
         </span>
         Increased calcium intake has been linked to reduced risk of colorectal cancer but may be associated with an increased risk of prostate cancer. There may be a minimum level of calcium intake, around 700 mg/day, that confers protection against colorectal cancer without significantly increasing prostate cancer risk.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Colorectal cancer –
         </strong>
         Multiple observational studies have demonstrated that higher calcium intake (either dietary or supplemental) is associated with a reduced risk of colorectal cancer [
         <a href="#rid151">
          151,152
         </a>
         ]. In a combined cohort from the Health Professionals Follow-up Study and Nurse's Health Study, the risk of distal, but not proximal, colon cancer was reduced in subjects who consumed more than 1250 mg/day elemental calcium versus ≤500 mg/day (relative risk [RR] 0.58, 95% CI 0.32-1.05) [
         <a href="#rid153">
          153
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Calcium supplementation also appears to prevent the recurrence of colorectal adenomas. Meta-analyses have found a 12 to 13 percent lower risk of recurrence of adenomas in patients randomized to calcium supplementation [
         <a href="#rid154">
          154,155
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2594.html" rel="external">
          "Overview of colon polyps"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, a protective effect of calcium supplementation was not shown by the Women's Health Initiative, which found no significant decrease in incidence or stage of colorectal cancer in the group assigned to receive calcium 500 mg and vitamin D 200 international units twice/day compared with placebo [
         <a href="#rid156">
          156
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         Overall, the World Cancer Research Fund Continuous Update Project panel concludes that “taking calcium supplements probably protects against colorectal cancer” [
         <a href="#rid148">
          148
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prostate cancer
         </strong>
         – Case-control and prospective studies of calcium and prostate cancer have reported inconsistent results [
         <a href="#rid157">
          157
         </a>
         ]. Three large cohort studies found an increased risk of prostate cancer with higher levels of calcium intake [
         <a href="#rid158">
          158-160
         </a>
         ]. Two other prospective studies found no association [
         <a href="#rid161">
          161,162
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6938.html" rel="external">
          "Risk factors for prostate cancer", section on 'Calcium and vitamin D'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H34459741">
         <span class="h3">
          Vitamin E
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evidence does not support a role for
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation in the prevention of cancer, and some evidence suggests that vitamin E supplementation may increase the risk of prostate cancer [
         <a href="#rid163">
          163,164
         </a>
         ]. In 2014, the US Preventive Services Task Force (USPSTF) made a recommendation against use of vitamin E for cancer prevention, but also noted that vitamin E has few or no substantial harms [
         <a href="#rid165">
          165
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">
          "Vitamin intake and disease prevention", section on 'Cancer'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">
          "Overview of vitamin E", section on 'Potential benefits'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h3">
          Folic acid
         </span>
         <span class="headingEndMark">
          —
         </span>
         The role of
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         in cancer prevention is uncertain and is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">
          "Vitamin intake and disease prevention", section on 'Cancer'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h3">
          Iron
         </span>
         <span class="headingEndMark">
          —
         </span>
         Observational studies suggest that increased iron stores or dietary iron may be associated with increased risk for cancer [
         <a href="#rid166">
          166,167
         </a>
         ]. A randomized trial conducted to evaluate the benefits of phlebotomy in patients with peripheral artery disease found a significant reduction in cancer incidence at six months (hazard ratio [HR] 0.65, 95% CI 0.43-0.97) in patients assigned to the phlebotomy group compared with controls [
         <a href="#rid168">
          168
         </a>
         ]. This finding warrants confirmation with additional trial data.
        </p>
        <p class="headingAnchor" id="H837737081">
         <span class="h3">
          Selenium
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although human epidemiologic studies and animal studies have suggested a potential protective effect of
         <a class="drug drug_general" data-topicid="9884" href="/z/d/drug information/9884.html" rel="external">
          selenium
         </a>
         on cancer incidence, randomized controlled human trials have not found a beneficial effect of selenium on overall cancer mortality or incidence [
         <a href="#rid169">
          169-173
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H244461827">
         <span class="h3">
          Vitamin A and carotenoids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trials evaluating vitamin A or carotenoid supplementation have reported no benefit or an increased risk of cancer. This is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">
          "Vitamin intake and disease prevention", section on 'Cancer'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4640.html" rel="external">
          "Cigarette smoking and other possible risk factors for lung cancer", section on 'Beta-carotene supplementation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h1">
          CHEMOPREVENTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chemoprevention for breast and prostate cancer are discussed in detail elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6949.html" rel="external">
          "Chemoprevention strategies in prostate cancer"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/756.html" rel="external">
          "Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/758.html" rel="external">
          "Cancer risks and management of BRCA1/2 carriers without cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H35">
         <span class="h2">
          Aspirin and other antiinflammatory drugs
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regular use of
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         and other nonsteroidal antiinflammatory drugs (NSAIDs) has been shown to decrease the risk of adenomatous polyps and colorectal cancer [
         <a href="#rid174">
          174-177
         </a>
         ]. In high-risk patients with Lynch syndrome, a randomized controlled trial found 600 mg/day of aspirin decreased the risk of colorectal cancer by 60 percent [
         <a href="#rid178">
          178
         </a>
         ]. The optimal dose of aspirin for patients at lower risk, however, has not been established [
         <a href="#rid179">
          179
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2600.html" rel="external">
          "NSAIDs (including aspirin): Role in prevention of colorectal cancer"
         </a>
         .)
        </p>
        <p>
         Several theories have been proposed for why
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         and other NSAIDs are effective in reducing colorectal cancer risk and possibly effective for other cancers. These medications may cause cell cycle arrest or apoptosis (programmed cell death) of abnormal cells. Reduced risk may also relate to irreversible inhibition of cyclooxygenase 2 (COX-2). Inhibition of this enzyme decreases the synthesis of prostaglandins, which may inhibit tumor growth. Finally, aspirin may influence intracellular signaling through inhibition of phospholipase activity.
        </p>
        <p>
         There are limited data to suggest that
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         is associated with a reduction in cancers other than colorectal. Use of aspirin and other NSAIDS for cancer prevention is discussed elsewhere(See
         <a class="medical medical_review" href="/z/d/html/16291.html" rel="external">
          "Aspirin in the primary prevention of cardiovascular disease and cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22765694">
         <span class="h2">
          Other medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although evidence is not compelling enough to suggest initiation of other drugs for cancer prevention, observational studies and limited experimental evidence suggest a possible future role for other drugs [
         <a href="#rid180">
          180-191
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H28310607">
         <span class="h3">
          Metformin
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          Metformin
         </a>
         has been associated with reduced incidence of several types of cancer in patients with type 2 diabetes.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A systematic review and meta-analysis included 11 independent studies contributing 4042 cases of cancer and 529 deaths in patients with diabetes [
         <a href="#rid183">
          183
         </a>
         ]. Both cancer incidence and cancer mortality were reduced by 30 percent among users of
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         . Reductions in the incidence of pancreatic and liver cancer as well as nonsignificant reductions for breast, colon, and prostate cancer were observed. There was a trend toward a dose-response relationship. In two subsequent meta-analyses in patients with diabetes, there was an association between metformin use and a decrease in colorectal cancer risk [
         <a href="#rid184">
          184
         </a>
         ] and a decrease in risk of colorectal, liver, and lung cancers [
         <a href="#rid185">
          185
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In an observational study of 4085 patients in the United Kingdom who used
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         for type 2 diabetes from 1994 to 2003, cancer incidence was 40 percent lower than among diabetic patients who did not take metformin (7.3 versus 11.6 percent, hazard ratio [HR] 0.46, 95% CI 0.40-0.53) [
         <a href="#rid181">
          181
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a prospective study of 1353 patients with type 2 diabetes in the Netherlands, during 9.6 years of follow-up, cancer mortality was reduced in those who used
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         (HR 0.43, CI 0.23-0.80) [
         <a href="#rid182">
          182
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a registry-based case control study in the United Kingdom,
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         use was associated with a substantial decrease in pancreatic cancer risk among women but had no effect on cancer risk among men [
         <a href="#rid186">
          186
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Among postulated mechanisms for such a benefit are the inhibition of cancer cell growth and suppression of HER2 overexpression and inhibition of mTOR [
         <a href="#rid187">
          187-189
         </a>
         ]. Alternatively, these results may reflect increased risk due to use of other regimens for diabetes rather than decreased risk due to use of
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         .
        </p>
        <p class="headingAnchor" id="H3020494597">
         <span class="h3">
          Warfarin
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies show mixed results regarding the association between
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         use and cancer risk [
         <a href="#rid191">
          191,192
         </a>
         ]. In a population-based cohort study of over one million people in Norway, warfarin users (for at least six months) had a lower incidence of all cancers diagnosed at least two years after initiating warfarin (incidence rate ratio [IRR] 0.84; 95% CI 0.82-0.86) [
         <a href="#rid191">
          191
         </a>
         ]. Warfarin users also had lower incidence of lung, prostate, and breast cancer. Warfarin is known to block murine tumorigenesis, and it is postulated that its biochemical actions enhance antitumor immune surveillance [
         <a href="#rid191">
          191
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H22765895">
         <span class="h3">
          Statins
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies of statins show mixed results; there is no convincing evidence that statins influence the risk of cancer. An association between statin use and decreased risk of a variety of cancers (particularly gastrointestinal and breast cancers) has been suggested in multiple observational studies; however, such data are subject to confounding by risk factors and comorbidities [
         <a href="#rid180">
          180
         </a>
         ]. By contrast, a meta-analysis of 27 randomized trials of statins (in which cancer prevention was not a primary outcome) did not find that statins reduced the incidence of any cancer [
         <a href="#rid190">
          190
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H108454350">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/886.html" rel="external">
          "Patient education: Medications for the prevention of breast cancer (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H39">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Many cancers are preventable. Basic lifestyle changes can have a tremendous impact on the rates of cancer. General lifestyle recommendations include avoiding tobacco, being physically active, maintaining a healthy weight, eating a healthy diet, limiting or eliminating alcohol, protecting against sexually transmitted infections, avoiding sun exposure, and obtaining appropriate cancer screening. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Human papillomavirus (HPV), hepatitis C virus (HCV), human T-lymphotropic virus type 1 (HTLV-1), HIV, hepatitis B virus (HBV), Epstein-Barr virus (EBV), and
         <em>
          Helicobacter pylori
         </em>
         have been linked to human cancers. Exposure prevention, pre-exposure prophylaxis (PrEP), screening, vaccination, and early treatment can help prevent infection-associated cancers. (See
         <a class="local">
          'Infections'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tobacco use is the most preventable cause of cancer. Significant health benefits accompany quitting, even for longtime tobacco users. The health benefits of quitting can be seen at all ages and can be measured almost immediately after cessation. (See
         <a class="local">
          'Tobacco use'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased physical activity appears to increase the risk for cancer. Physical activity is associated with a decreased risk for many different types of cancers [
         <a href="#rid47">
          47
         </a>
         ], but the most compelling data are in the reduction in colon and breast cancer risk. (See
         <a class="local">
          'Physical activity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obesity has been found to increase the risk of many types of cancers, and weight loss decreases risk. (See
         <a class="local">
          'Obesity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alcohol intake, even in light to moderate quantities, increases the risk for colon, breast, esophageal, and oropharyngeal cancer. (See
         <a class="local">
          'Alcohol'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Potentially modifiable or avoidable environmental contributors to cancer incidence include exposure to excessive solar radiation or to artificial ultraviolet radiation, air pollution, radon gas in enclosed environments, and arsenic in drinking water. (See
         <a class="local">
          'Environmental exposures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Skin cancer is directly related to natural and artificial ultraviolet exposure. A history of blistering sunburns and indoor tanning, especially in youth and young adults, is of particular risk for melanoma; cumulative sun exposure has more impact on non-melanoma cancers. (See
         <a class="local">
          'Environmental exposures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The association of dietary fat, fruits, and vegetables with cancer risk is largely unconfirmed. Red meat and processed meat consumption may promote colorectal cancer and a high intake of tomatoes probably decreases prostate cancer risk. (See
         <a class="local">
          'Diet'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         High calcium intake (&gt;2000 mg/day) increases risk for prostate cancer but is associated with a reduced risk of colorectal cancer. Folate in diet has been associated with a decreased risk of colon cancer, especially in women who drink alcohol; data on
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         or multivitamin supplementation are inconsistent. (See
         <a class="local">
          'Vitamins and micronutrients'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chemoprevention may be helpful in high-risk patients, but risks and benefits should be weighed carefully.
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          Aspirin
         </a>
         and nonsteroidal antiinflammatory drugs (NSAIDs) offer protection against adenomatous polyps and colorectal cancer, and long-term use in low doses likely decreases cancer-related mortality risk from other solid tumors. (See
         <a class="local">
          'Chemoprevention'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Colditz GA, Wolin KY, Gehlert S. Applying what we know to accelerate cancer prevention. Sci Transl Med 2012; 4:127rv4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Emmons KM, Colditz GA. Realizing the Potential of Cancer Prevention - The Role of Implementation Science. N Engl J Med 2017; 376:986.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romaguera D, Vergnaud AC, Peeters PH, et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr 2012; 96:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ford ES, Bergmann MM, Kröger J, et al. Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch Intern Med 2009; 169:1355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Schoufour J, Wang DD, et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. BMJ 2020; 368:l6669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harvard Center for Cancer Prevention. Harvard report on cancer prevention: Volume 2: Prevention of human cancer. Cancer Causes Control 1997; 8:S1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Danaei G, Vander Hoorn S, Lopez AD, et al. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366:1784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tran KB, Lang JJ, Compton K, et al. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022; 400:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 2020; 8:e180.
          </a>
         </li>
         <li class="breakAll">
          Mueller N. Infectious agents. In: Cancer Prevention: The Causes and Prevention of Cancer, Colditz G, Hunter D (Eds), Springer, 2000. p.63.
         </li>
         <li class="breakAll">
          International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses, 1995. Vol 64.
         </li>
         <li class="breakAll">
          International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Hepatitis Viruses, 1994. Vol 59.
         </li>
         <li class="breakAll">
          International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Immunodeficiency Viruses and Human T-Cell Lumphotropic Viruses, 1996. Vol 67.
         </li>
         <li class="breakAll">
          American Cancer Society. Cancer Facts and Figures 2005. Available at: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures.html (Accessed on June 28, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deeken JF, Tjen-A-Looi A, Rudek MA, et al. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis 2012; 55:1228.
          </a>
         </li>
         <li class="breakAll">
          International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, Liver Flukes, and Helicobacter Pylori, 1994. Vol 61.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malnati MS, Dagna L, Ponzoni M, Lusso P. Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. Rev Clin Exp Hematol 2003; 7:375.
          </a>
         </li>
         <li class="breakAll">
          International Agency for Research on Cacner (IARC). IARC Monographcs on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, Liver Flukes, and Helicobacter Pylori, 1994. Vol 61.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xia J, Jiang SC, Peng HJ. Association between Liver Fluke Infection and Hepatobiliary Pathological Changes: A Systematic Review and Meta-Analysis. PLoS One 2015; 10:e0132673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American College of Obstetricians and Gynecologists. ACOG practice bulletin. Cervical Cytology screening. Number 45, August 2003. Int J Gynaecol Obstet 2003; 83:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2020; 323:970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Little RF. AIDS-related non-Hodgkin's lymphoma: etiology, epidemiology, and impact of highly active antiretroviral therapy. Leuk Lymphoma 2003; 44 Suppl 3:S63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sung JJ, Tsoi KK, Wong VW, et al. Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. Aliment Pharmacol Ther 2008; 28:1067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lok AS, McMahon BJ, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology 2004; 39:857.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strader DB, Wright T, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brawley OW. Avoidable cancer deaths globally. CA Cancer J Clin 2011; 61:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henley SJ, Thomas CC, Sharapova SR, et al. Vital Signs: Disparities in Tobacco-Related Cancer Incidence and Mortality - United States, 2004-2013. MMWR Morb Mortal Wkly Rep 2016; 65:1212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. MMWR Morb Mortal Wkly Rep 2002; 51:300.
          </a>
         </li>
         <li class="breakAll">
          Colditz G, Ryan CT, Dart CH. Lifestyle behaviors contributing to the burden of cancer. In: Fulfilling the Potential of Cancer Prevention and Early Detection, Curry S, Byers T, Hewitt M (Eds), The National Academies Press, 2003.
         </li>
         <li class="breakAll">
          Thun M, Day-Lally C, Myers E, et al. Trends in tobacco smoking and mortality from cigarette use in Cancer Prevention Studies I (1959 through 1965) and II (1982 through 1988). In: Changes in Cigarette-related Disease Risk and their Implications for Prevention and Control, Burns D, Garfinkel L, Samet J (Eds), National Institute of Health, 1997.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 2004; 45 Suppl 2:S3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brownson RC, Novotny TE, Perry MC. Cigarette smoking and adult leukemia. A meta-analysis. Arch Intern Med 1993; 153:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy AB, Akereyeni F, Nyame YA, et al. Smoking and prostate cancer in a multi-ethnic cohort. Prostate 2013; 73:1518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA 2011; 305:2548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Islami F, Moreira DM, Boffetta P, Freedland SJ. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol 2014; 66:1054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macacu A, Autier P, Boniol M, Boyle P. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat 2015; 154:213.
          </a>
         </li>
         <li class="breakAll">
          The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. (Ed), Centers for Disease Control and Prevention (US), Atlanta (GA) 2014.
         </li>
         <li class="breakAll">
          US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. US Department of Health and Human Services, Atlanta, GA 2004.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Samet JM. The 1990 Report of the Surgeon General: The Health Benefits of Smoking Cessation. Am Rev Respir Dis 1990; 142:993.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004; 96:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. JAMA 1996; 275:1270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA 2000; 283:3244.
          </a>
         </li>
         <li class="breakAll">
          Fulfilling the Potential of Cancer Prevention and Early Detection, Institute of Medicine (US) and National Research Council (US) National Cancer Policy Board. (Ed), National Academies Press (US), Washington (DC) 2003.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matthews CE, Moore SC, Arem H, et al. Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk. J Clin Oncol 2020; 38:686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore SC, Lee IM, Weiderpass E, et al. Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA Intern Med 2016; 176:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inoue M, Yamamoto S, Kurahashi N, et al. Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohort study in Japan. Am J Epidemiol 2008; 168:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harvard Report on Cancer Prevention. Volume 1: Causes of human cancer. Cancer Causes Control 1996; 7 Suppl 1:S3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maruti SS, Willett WC, Feskanich D, et al. A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 2008; 100:728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernstein L. Exercise and breast cancer prevention. Curr Oncol Rep 2009; 11:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolin KY, Yan Y, Colditz GA, Lee IM. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer 2009; 100:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Antonelli JA, Jones LW, Bañez LL, et al. Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy. J Urol 2009; 182:2226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel AV, Rodriguez C, Jacobs EJ, et al. Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men. Cancer Epidemiol Biomarkers Prev 2005; 14:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colditz GA, Cannuscio CC, Frazier AL. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control 1997; 8:649.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dallal CM, Sullivan-Halley J, Ross RK, et al. Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med 2007; 167:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chao A, Connell CJ, Jacobs EJ, et al. Amount, type, and timing of recreational physical activity in relation to colon and rectal cancer in older adults: the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2004; 13:2187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martínez ME, Giovannucci E, Spiegelman D, et al. Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 1997; 89:948.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rockhill B, Willett WC, Hunter DJ, et al. A prospective study of recreational physical activity and breast cancer risk. Arch Intern Med 1999; 159:2290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu FB, Willett WC, Li T, et al. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 2004; 351:2694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyle T, Keegel T, Bull F, et al. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst 2012; 104:1548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolin KY, Yan Y, Colditz GA. Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer 2011; 104:882.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994; 3:687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannucci E, Ascherio A, Rimm EB, et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995; 122:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martínez ME, Heddens D, Earnest DL, et al. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst 1999; 91:950.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med 2016; 375:794.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357:753.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort. Ann Surg 2019; 269:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA 2006; 296:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luo J, Chlebowski RT, Hendryx M, et al. Intentional Weight Loss and Endometrial Cancer Risk. J Clin Oncol 2017; 35:1189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebowski RT, Luo J, Anderson GL, et al. Weight loss and breast cancer incidence in postmenopausal women. Cancer 2019; 125:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7:599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Theruvathu JA, Jaruga P, Nath RG, et al. Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res 2005; 33:3513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006; 7:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armstrong BK, Cust AE. Sun exposure and skin cancer, and the puzzle of cutaneous melanoma: A perspective on Fears et al. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. American Journal of Epidemiology 1977; 105: 420-427. Cancer Epidemiol 2017; 48:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer 2007; 120:1116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum 2004; 84:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baris D, Waddell R, Beane Freeman LE, et al. Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. J Natl Cancer Inst 2016; 108.
          </a>
         </li>
         <li class="breakAll">
          https://www.who.int/publications/i/item/9789241512596 (Accessed on June 28, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Key TJ. Fruit and vegetables and cancer risk. Br J Cancer 2011; 104:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boffetta P, Couto E, Wichmann J, et al. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2010; 102:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin 2020; 70:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grosso G, Bella F, Godos J, et al. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutr Rev 2017; 75:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benetou V, Trichopoulou A, Orfanos P, et al. Conformity to traditional Mediterranean diet and cancer incidence: the Greek EPIC cohort. Br J Cancer 2008; 99:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Couto E, Boffetta P, Lagiou P, et al. Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer 2011; 104:1493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le LT, Sabaté J. Beyond meatless, the health effects of vegan diets: findings from the Adventist cohorts. Nutrients 2014; 6:2131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brennan SF, Cantwell MM, Cardwell CR, et al. Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr 2010; 91:1294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fiolet T, Srour B, Sellem L, et al. Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort. BMJ 2018; 360:k322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan DS, Lau R, Aune D, et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 2011; 6:e20456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu K, Spiegelman D, Hou T, et al. Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies. Int J Cancer 2016; 138:2368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolk A. Potential health hazards of eating red meat. J Intern Med 2017; 281:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouvard V, Loomis D, Guyton KZ, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol 2015; 16:1599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benetou V, Orfanos P, Lagiou P, et al. Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study. Cancer Epidemiol Biomarkers Prev 2008; 17:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takachi R, Inoue M, Ishihara J, et al. Fruit and vegetable intake and risk of total cancer and cardiovascular disease: Japan Public Health Center-Based Prospective Study. Am J Epidemiol 2008; 167:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hung HC, Joshipura KJ, Jiang R, et al. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 2004; 96:1577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           George SM, Park Y, Leitzmann MF, et al. Fruit and vegetable intake and risk of cancer: a prospective cohort study. Am J Clin Nutr 2009; 89:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feskanich D, Ziegler RG, Michaud DS, et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000; 92:1812.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith-Warner SA, Spiegelman D, Yaun SS, et al. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA 2001; 285:769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michels KB, Edward Giovannucci, Joshipura KJ, et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 2000; 92:1740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koushik A, Hunter DJ, Spiegelman D, et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 2007; 99:1471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JE, Chan AT. Fruit, vegetables, and folate: cultivating the evidence for cancer prevention. Gastroenterology 2011; 141:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011; 343:d6617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kavanaugh CJ, Trumbo PR, Ellwood KC. The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst 2007; 99:1074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zu K, Mucci L, Rosner BA, et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst 2014; 106:djt430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung S, Spiegelman D, Baglietto L, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst 2013; 105:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008; 98:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang G, Shu XO, Chow WH, et al. Soy food intake and risk of lung cancer: evidence from the Shanghai Women's Health Study and a meta-analysis. Am J Epidemiol 2012; 176:846.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fink BN, Steck SE, Wolff MS, et al. Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 2007; 165:514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shin MH, Holmes MD, Hankinson SE, et al. Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst 2002; 94:1301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knekt P, Järvinen R, Seppänen R, et al. Intake of dairy products and the risk of breast cancer. Br J Cancer 1996; 73:687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd NF, Martin LJ, Noffel M, et al. A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer 1993; 68:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin J, Manson JE, Lee IM, et al. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007; 167:1050.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Missmer SA, Smith-Warner SA, Spiegelman D, et al. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol 2002; 31:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qin LQ, Xu JY, Wang PY, et al. Milk/dairy products consumption, galactose metabolism and ovarian cancer: meta-analysis of epidemiological studies. Eur J Cancer Prev 2005; 14:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Genkinger JM, Hunter DJ, Spiegelman D, et al. Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2006; 15:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larsson SC, Orsini N, Wolk A. Milk, milk products and lactose intake and ovarian cancer risk: a meta-analysis of epidemiological studies. Int J Cancer 2006; 118:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA. Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer 2006; 94:165.
          </a>
         </li>
         <li class="breakAll">
          World Cancer Research Fund. Colorectal cancer: How diet, nutrition and physical activity affect colorectal (bowel) cancer risk. Available at: https://www.wcrf.org/dietandcancer/colorectal-cancer (Accessed on April 28, 2020).
         </li>
         <li class="breakAll">
          Norat T, Vieira AR, Abar L, et al. World Cancer Research Fund international systematic literature review: The associations between food, nutrition and physical activity and the risk of colorectal cancer. Available at: https://www.wcrf.org/sites/default/files/colorectal-cancer-slr.pdf (Accessed on April 28, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6:164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin 2010; 60:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vigneri P, Frasca F, Sciacca L, et al. Diabetes and cancer. Endocr Relat Cancer 2009; 16:1103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           George SM, Mayne ST, Leitzmann MF, et al. Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 2009; 169:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Augustin LS, Dal Maso L, La Vecchia C, et al. Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol 2001; 12:1533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jonas CR, McCullough ML, Teras LR, et al. Dietary glycemic index, glycemic load, and risk of incident breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2003; 12:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmes MD, Liu S, Hankinson SE, et al. Dietary carbohydrates, fiber, and breast cancer risk. Am J Epidemiol 2004; 159:732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen TG, Olsen A, Christensen J, et al. Dietary carbohydrate intake is not associated with the breast cancer incidence rate ratio in postmenopausal Danish women. J Nutr 2005; 135:124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higginbotham S, Zhang ZF, Lee IM, et al. Dietary glycemic load and breast cancer risk in the Women's Health Study. Cancer Epidemiol Biomarkers Prev 2004; 13:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romieu I, Ferrari P, Rinaldi S, et al. Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr 2012; 96:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dong JY, Qin LQ. Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies. Breast Cancer Res Treat 2011; 126:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shikany JM, Flood AP, Kitahara CM, et al. Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Cancer Causes Control 2011; 22:995.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higginbotham S, Zhang ZF, Lee IM, et al. Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst 2004; 96:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slattery ML, Curtin K, Ma K, et al. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev 2002; 11:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Terry PD, Jain M, Miller AB, et al. Glycemic load, carbohydrate intake, and risk of colorectal cancer in women: a prospective cohort study. J Natl Cancer Inst 2003; 95:914.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michaud DS, Fuchs CS, Liu S, et al. Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2005; 14:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aune D, Chan DS, Lau R, et al. Carbohydrates, glycemic index, glycemic load, and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Cancer Causes Control 2012; 23:521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 2006; 295:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andreeva VA, Touvier M, Kesse-Guyot E, et al. B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial. Arch Intern Med 2012; 172:540.
          </a>
         </li>
         <li class="breakAll">
          World Cancer Research Fund. Endometrial cancer: How diet, nutrition and physical activity affect endometrial (womb) cancer risk. Available at: https://www.wcrf.org/dietandcancer/endometrial-cancer (Accessed on April 28, 2020).
         </li>
         <li class="breakAll">
          World Cancer Research Fund. Liver cancer: How diet, nutrition and physical activity affect endometrial (womb) cancer risk. Available at: https://www.wcrf.org/dietandcancer/liver-cancer (Accessed on April 28, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vastag B. Nutrients for prevention: negative trials send researchers back to drawing board. J Natl Cancer Inst 2009; 101:446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coulter ID, Hardy ML, Morton SC, et al. Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer. J Gen Intern Med 2006; 21:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009; 101:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neuhouser ML, Wassertheil-Smoller S, Thomson C, et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med 2009; 169:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park SY, Murphy SP, Wilkens LR, et al. Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study. Am J Epidemiol 2011; 173:906.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaziano JM, Sesso HD, Christen WG, et al. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2012; 308:1871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qiao YL, Dawsey SM, Kamangar F, et al. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 2009; 101:507.
          </a>
         </li>
         <li class="breakAll">
          World Cancer Research Fund, American Institute for Cancer Research. Recommendations and public health policy implications. Available at: https://www.wcrf.org/wp-content/uploads/2021/01/Recommendations.pdf (Accessed on May 26, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung M, Lee J, Terasawa T, et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155:827.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freedman DM, Looker AC, Abnet CC, et al. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res 2010; 70:8587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pietinen P, Malila N, Virtanen M, et al. Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control 1999; 10:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garland C, Shekelle RB, Barrett-Connor E, et al. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985; 1:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu K, Willett WC, Fuchs CS, et al. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 2002; 94:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonovas S, Fiorino G, Lytras T, et al. Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials. World J Gastroenterol 2016; 22:4594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veettil SK, Ching SM, Lim KG, et al. Effects of calcium on the incidence of recurrent colorectal adenomas: A systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Medicine (Baltimore) 2017; 96:e7661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354:684.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 2001; 23:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannucci E, Rimm EB, Wolk A, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998; 58:442.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan JM, Stampfer MJ, Ma J, et al. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr 2001; 74:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodriguez C, McCullough ML, Mondul AM, et al. Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men. Cancer Epidemiol Biomarkers Prev 2003; 12:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schuurman AG, van den Brandt PA, Dorant E, Goldbohm RA. Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study. Br J Cancer 1999; 80:1107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan JM, Pietinen P, Virtanen M, et al. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 2000; 11:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306:1549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moyer VA, U.S. Preventive Services Task Force. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement. Ann Intern Med 2014; 160:558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Asperen IA, Feskens EJ, Bowles CH, Kromhout D. Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women. Int J Epidemiol 1995; 24:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knekt P, Reunanen A, Takkunen H, et al. Body iron stores and risk of cancer. Int J Cancer 1994; 56:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zacharski LR, Chow BK, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008; 100:996.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark LC. The epidemiology of selenium and cancer. Fed Proc 1985; 44:2584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Combs GF Jr. Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 2005; 135:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steevens J, van den Brandt PA, Goldbohm RA, Schouten LJ. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology 2010; 138:1704.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vinceti M, Dennert G, Crespi CM, et al. Selenium for preventing cancer. Cochrane Database Syst Rev 2014; 2014:CD005195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vinceti M, Filippini T, Del Giovane C, et al. Selenium for preventing cancer. Cochrane Database Syst Rev 2018; 1:CD005195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jänne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med 2000; 342:1960.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baron JA. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 2003; 37:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobs EJ, Thun MJ, Bain EB, et al. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 2007; 99:608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flossmann E, Rothwell PM, British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369:1603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan AT, Lippman SM. Aspirin and colorectal cancer prevention in Lynch syndrome. Lancet 2011; 378:2051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandler RS. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer. Important Adv Oncol 1996; :123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gronich N, Rennert G. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol 2013; 10:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Libby G, Donnelly LA, Donnan PT, et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 2009; 32:1620.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Landman GW, Kleefstra N, van Hateren KJ, et al. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 2010; 33:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Decensi A, Puntoni M, Goodwin P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2010; 3:1451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang ZJ, Zheng ZJ, Kan H, et al. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care 2011; 34:2323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noto H, Goto A, Tsujimoto T, Noda M. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One 2012; 7:e33411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bodmer M, Becker C, Meier C, et al. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. Am J Gastroenterol 2012; 107:620.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alimova IN, Liu B, Fan Z, et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 2009; 8:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells. Cell Cycle 2009; 8:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vázquez-Martín A, Oliveras-Ferraros C, del Barco S, et al. mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). Clin Transl Oncol 2009; 11:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cholesterol Treatment Trialists' (CTT) Collaboration, Emberson JR, Kearney PM, et al. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One 2012; 7:e29849.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haaland GS, Falk RS, Straume O, Lorens JB. Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years. JAMA Intern Med 2017; 177:1774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tagalakis V, Blostein M, Robinson-Cohen C, Kahn SR. The effect of anticoagulants on cancer risk and survival: systematic review. Cancer Treat Rev 2007; 33:358.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6893 Version 83.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22461645" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Applying what we know to accelerate cancer prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28273020" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Realizing the Potential of Cancer Prevention - The Role of Implementation Science.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30207593" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22592101" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19667296" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31915124" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Harvard report on cancer prevention: Volume 2: Prevention of human cancer
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16298215" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31862245" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31862245" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31862245" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31862245" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31862245" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31862245" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22776851" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The rising challenge of non-AIDS-defining cancers in HIV-infected patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22776851" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The rising challenge of non-AIDS-defining cancers in HIV-infected patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15129649" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15129649" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26186510" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Association between Liver Fluke Infection and Hepatobiliary Pathological Changes: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14631934" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : ACOG practice bulletin. Cervical Cytology screening. Number 45, August 2003.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32119076" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15202527" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : AIDS-related non-Hodgkin's lymphoma: etiology, epidemiology, and impact of highly active antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18657133" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14999707" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Chronic hepatitis B: update of recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15057920" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Diagnosis, management, and treatment of hepatitis C.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21296854" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Avoidable cancer deaths globally.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27832048" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Vital Signs: Disparities in Tobacco-Related Cancer Incidence and Mortality - United States, 2004-2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12002168" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12002168" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12002168" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15552776" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Tobacco smoking and cancer: a brief review of recent epidemiological evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8435026" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Cigarette smoking and adult leukemia. A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23824512" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Smoking and prostate cancer in a multi-ethnic cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21693743" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Smoking and prostate cancer survival and recurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25242554" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26546245" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Active and passive smoking and risk of breast cancer: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26546245" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Active and passive smoking and risk of breast cancer: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26546245" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Active and passive smoking and risk of breast cancer: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2240852" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The 1990 Report of the Surgeon General: The Health Benefits of Smoking Cessation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14734699" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Tobacco and cancer: recent epidemiological evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8601960" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10866874" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10866874" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31877085" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27183032" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18599492" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohort study in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9091058" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Harvard Report on Cancer Prevention. Volume 1: Causes of human cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18477801" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : A prospective study of age-specific physical activity and premenopausal breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19840527" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Exercise and breast cancer prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19209175" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Physical activity and colon cancer prevention: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19758620" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15668508" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9242482" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Physical activity and reduced risk of colon cancer: implications for prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17325304" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15598779" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Amount, type, and timing of recreational physical activity in relation to colon and rectal cancer in older adults: the Cancer Prevention Study II Nutrition Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9214674" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10547168" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : A prospective study of recreational physical activity and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15616204" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Adiposity as compared with physical activity in predicting mortality among women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22914790" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21304525" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Physical activity and risk of colon adenoma: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7881343" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7847643" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Physical activity, obesity, and risk for colon cancer and adenoma in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10359547" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27557308" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Body Fatness and Cancer--Viewpoint of the IARC Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17715409" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Long-term mortality after gastric bypass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28938270" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16835425" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Adult weight change and risk of postmenopausal breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28165909" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Intentional Weight Loss and Endometrial Cancer Risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30294816" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Weight loss and breast cancer incidence in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17646865" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Molecular mechanisms of alcohol-mediated carcinogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15972793" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16455479" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Alcohol and cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28478931" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Sun exposure and skin cancer, and the puzzle of cutaneous melanoma: A perspective on Fears et al. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. American Journal of Epidemiology 1977; 105: 420-427.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11227927" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17131335" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15645577" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Some drinking-water disinfectants and contaminants, including arsenic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27140955" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27140955" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21119663" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Fruit and vegetables and cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20371762" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32515498" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : American Cancer Society guideline for diet and physical activity for cancer prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28969358" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18594542" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Conformity to traditional Mediterranean diet and cancer incidence: the Greek EPIC cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21468044" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Mediterranean dietary pattern and cancer risk in the EPIC cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24871675" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Beyond meatless, the health effects of vegan diets: findings from the Adventist cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20219961" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Dietary patterns and breast cancer risk: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29444771" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santéprospective cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21674008" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26685908" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27597529" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Potential health hazards of eating red meat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26514947" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Carcinogenicity of consumption of red and processed meat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18268122" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17928402" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Fruit and vegetable intake and risk of total cancer and cardiovascular disease: Japan Public Health Center-Based Prospective Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15523086" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Fruit and vegetable intake and risk of major chronic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19056579" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Fruit and vegetable intake and risk of cancer: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11078758" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11176915" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11058617" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17895473" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21620843" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Fruit, vegetables, and folate: cultivating the evidence for cancer prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22074852" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17623802" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24463248" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23349252" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Fruit and vegetable intake and risk of breast cancer by hormone receptor status.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18182974" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Epidemiology of soy exposures and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23097255" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Soy food intake and risk of lung cancer: evidence from the Shanghai Women's Health Study and a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17158855" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Dietary flavonoid intake and breast cancer risk among women on Long Island.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12208895" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Intake of dairy products, calcium, and vitamin d and risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8605108" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Intake of dairy products and the risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8353053" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : A meta-analysis of studies of dietary fat and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17533208" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Intakes of calcium and vitamin D and breast cancer risk in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11914299" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15677891" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Milk/dairy products consumption, galactose metabolism and ovarian cancer: meta-analysis of epidemiological studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16492930" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16052536" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Milk, milk products and lactose intake and ovarian cancer risk: a meta-analysis of epidemiological studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16306872" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16306872" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16306872" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7749056" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Insulin and colon cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20554718" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Diabetes and cancer: a consensus report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19620249" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Diabetes and cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19095757" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11822751" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12815005" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Dietary glycemic index, glycemic load, and risk of incident breast cancer in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15051582" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Dietary carbohydrates, fiber, and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15623843" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Dietary carbohydrate intake is not associated with the breast cancer incidence rate ratio in postmenopausal Danish women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14744735" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Dietary glycemic load and breast cancer risk in the Women's Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22760570" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21221764" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21553078" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14759990" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Dietary glycemic load and risk of colorectal cancer in the Women's Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12050095" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Diet activity, and lifestyle associations with p53 mutations in colon tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12813175" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Glycemic load, carbohydrate intake, and risk of colorectal cancer in women: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15668487" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22418776" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Carbohydrates, glycemic index, glycemic load, and colorectal cancer risk: a systematic review and meta-analysis of cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16434631" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Effects of omega-3 fatty acids on cancer risk: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22331983" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : B vitamin and/orω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22331983" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : B vitamin and/orω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22331983" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : B vitamin and/orω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19318633" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Nutrients for prevention: negative trials send researchers back to drawing board.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16808775" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19116389" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19204221" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21343248" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23162860" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19318634" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19318634" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22184690" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20847342" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10530608" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Diet and risk of colorectal cancer in a cohort of Finnish men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2857364" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11904316" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Calcium intake and risk of colon cancer in women and men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27182169" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28796047" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Effects of calcium on the incidence of recurrent colorectal adenomas: A systematic review with meta-analysis and trial sequential analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16481636" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Calcium plus vitamin D supplementation and the risk of colorectal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11588859" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Dairy products, calcium, and vitamin D and risk of prostate cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9458087" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Calcium and fructose intake in relation to risk of prostate cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11566656" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12869397" id="rid159" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          160 : Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10362125" id="rid160" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          161 : Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11075876" id="rid161" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          162 : Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19066370" id="rid162" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          163 : Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21990298" id="rid163" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          164 : Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24566474" id="rid164" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          165 : Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8550261" id="rid165" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          166 : Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8314326" id="rid166" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          167 : Body iron stores and risk of cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18612130" id="rid167" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          168 : Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3996614" id="rid168" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          169 : The epidemiology of selenium and cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15671240" id="rid169" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          170 : Current evidence and research needs to support a health claim for selenium and cancer prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20006613" id="rid170" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          171 : Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24683040" id="rid171" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          172 : Selenium for preventing cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29376219" id="rid172" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          173 : Selenium for preventing cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10874065" id="rid173" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          174 : Chemoprevention of colorectal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12795046" id="rid174" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          175 : Epidemiology of non-steroidal anti-inflammatory drugs and cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17440162" id="rid175" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          176 : A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17499602" id="rid176" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          177 : Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22036018" id="rid177" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          178 : Aspirin and colorectal cancer prevention in Lynch syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8791132" id="rid178" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          179 : Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24080598" id="rid179" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          180 : Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19564453" id="rid180" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          181 : New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19918015" id="rid181" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          182 : Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20947488" id="rid182" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          183 : Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21949223" id="rid183" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          184 : Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22448244" id="rid184" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          185 : Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22290402" id="rid185" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          186 : Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19221498" id="rid186" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          187 : Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19106626" id="rid187" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          188 : The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19574203" id="rid188" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          189 : mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22276132" id="rid189" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          190 : Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29114736" id="rid190" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          191 : Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17408861" id="rid191" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          192 : The effect of anticoagulants on cancer risk and survival: systematic review.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
